Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Novel peptide agonists, favoring galanin receptor type 2 over galanin receptor type 1 and 3
Stockholms universitet, Naturvetenskapliga fakulteten, Institutionen för neurokemi.
Stockholms universitet, Naturvetenskapliga fakulteten, Institutionen för neurokemi.
Stockholms universitet, Naturvetenskapliga fakulteten, Institutionen för neurokemi.ORCID-id: 0000-0001-6107-0844
2009 (engelsk)Inngår i: The FEBS Journal, ISSN 1742-464X, E-ISSN 1742-4658, Vol. 276, s. 164-164Artikkel i tidsskrift, Meeting abstract (Fagfellevurdert) Published
Abstract [en]

The galanin peptide family and its three receptors have with compelling evidence been implicated in a variety of human disorders. The co-localization with other neuromodulators and the distinct up-regulation during and after pathological disturbances has drawn attention to this neuropeptide family although, so far, no therapeutics have emerged past the animal model stage. In the current study we present data on receptor binding and functional response from novel galanin receptor type 2 (GalR2) selective chimeric peptides, including the M1145 peptide which show more than 90-fold higher affinity for galanin receptor type 2 over galanin receptor type 1 and a 76-fold higher affinity over galanin receptor type 3. Furthermore, the peptide produces an agonistic effect in vitro seen as an increase in inositol phosphate (IP) accumulation, both in the absence or the presence of galanin. The peptide design with a N-terminal extension of galanin(2-13), prevails new insights in the assembly of novel subtype specific ligands for the galanin receptor family. Preliminary data on peptides further exploring the usage of N-terminal extension shows even higher preferentiality towards the GalR2 and opens new possibilities to clarify the galanin system as a putative drug target.

sted, utgiver, år, opplag, sider
2009. Vol. 276, s. 164-164
HSV kategori
Forskningsprogram
neurokemi med molekylär neurobiologi
Identifikatorer
URN: urn:nbn:se:su:diva-45997DOI: 10.1111/j.1742-4658.2009.07049.xOAI: oai:DiVA.org:su-45997DiVA, id: diva2:370826
Konferanse
34th Congress of the Federation-of-European-Biochemical-Societies, July 04-09, 2009, Prague, Czech Republic
Merknad

Special Issue: Abstracts of the 34th FEBS Congress

Tilgjengelig fra: 2013-01-07 Laget: 2010-11-18 Sist oppdatert: 2017-12-12bibliografisk kontrollert

Open Access i DiVA

Poster FEBS(1732 kB)89 nedlastinger
Filinformasjon
Fil FULLTEXT02.pdfFilstørrelse 1732 kBChecksum SHA-512
cc26e439a5b6ab0c1e2e1dcb7637f783d76f62fb899fb9e932a24d2ef7a5c96b5f3059cd515759c1c1a785e8fd51fe7a2acb05062ac38593d5c1dd1b4b5f17d0
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekst

Søk i DiVA

Av forfatter/redaktør
Runesson, JohanLangel, Ülo
Av organisasjonen
I samme tidsskrift
The FEBS Journal

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 89 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
urn-nbn

Altmetric

doi
urn-nbn
Totalt: 60 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf